Sign In
Buy MLYS
Mineralys Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -2.19. In total, the insiders bought 1.57M and sold 384.5K MLYS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-2.19 |
| ● Buy | 1.57M shares |
| ● Sell | 384.5K shares |
|
70% Buy Activity
Moderate Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jul 09, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
2 171 Value: $34.7K |
||
|
Jul 09, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
2 171 Value: $34.7K |
||
|
Jul 09, 2026 Sell |
Rodman David Malcom Chief Medical Officer |
2 171 Value: $65.8K |
||
|
Jun 30, 2026 Sell |
Congleton Jon Chief Executive Officer |
58 000 Value: $1.50M |
||
|
Jun 30, 2026 Sell |
Congleton Jon Chief Executive Officer |
17 000 Value: $455.9K |
||
|
Jun 26, 2026 Sell |
Warren Eric Chief Commercial Officer |
104 124 Value: $2.70M |
||
|
Jun 26, 2026 Buy |
Warren Eric Chief Commercial Officer |
104 124 Value: $1.38M |
||
|
Jun 26, 2026 Buy |
Warren Eric Chief Commercial Officer |
104 124 Value: $1.38M |
||
|
Jun 17, 2026 Buy |
Karydas Daphne Director |
3 000 Value: $36.1K |
||
|
Jun 17, 2026 Buy |
Karydas Daphne Director |
3 000 Value: $36.1K |
||
|
Jun 17, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
4 167 Value: $59.4K |
||
|
Jun 17, 2026 Sell |
Karydas Daphne Director |
3 000 Value: $75.0K |
||
|
Jun 17, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
417 Value: $6K |
||
|
Jun 17, 2026 Sell |
Rodman David Malcom Chief Medical Officer |
4 584 Value: $114.6K |
||
|
Jun 17, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
4 167 Value: $59.4K |
||
|
Jun 17, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
417 Value: $6K |
||
|
Jun 15, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
3 542 Value: $36.1K |
||
|
Jun 15, 2026 Sell |
Rodman David Malcom Chief Medical Officer |
9 890 Value: $235.5K |
||
|
Jun 15, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
3 542 Value: $36.1K |
||
|
Jun 12, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
6 349 Value: $7K |
||
|
Jun 12, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
6 349 Value: $7K |
||
|
Jun 12, 2026 Sell |
Rodman David Malcom Chief Medical Officer |
6 349 Value: $151.9K |
||
|
Jun 10, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
2 170 Value: $34.7K |
||
|
Jun 10, 2026 Buy |
Rodman David Malcom Chief Medical Officer |
2 170 Value: $34.7K |
||
|
Jun 10, 2026 Sell |
Rodman David Malcom Chief Medical Officer |
2 170 Value: $54.3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
